Lv7
4750 积分 2021-11-18 加入
State-of-the-art evidence in the treatment of systemic sclerosis
1天前
已完结
Chimeric Antigen Receptor T-Cell Therapy for Solid Tumors
5个月前
已完结
Strategies for modifying the chimeric antigen receptor (CAR) to improve safety and reduce toxicity in CAR T cell therapy for cancer
5个月前
已完结
Docetaxel enhances the therapeutic efficacy of PSMA-specific CAR-T cells against prostate cancer models by suppressing MDSCs
5个月前
已完结
Comparative efficacy of ciltacabtagene autoleucel versus idecabtagene vicleucel in the treatment of patients with relapsed or refractory multiple myeloma previously treated with 2–4 prior lines of therapy: a matching-adjusted indirect comparison
7个月前
已完结
CAR T-cell therapy in aggressive lymphomas—identifying prognostic and predictive markers
7个月前
已完结
Clofarabine for Lymphodepletion Before CAR-T-Cell Infusion: A Brief Case Report
8个月前
已完结
Autologous HER2-specific CAR T cells after lymphodepletion for advanced sarcoma: a phase 1 trial
8个月前
已完结
Phase I Trial of Anti‐PSMA Designer CAR‐T Cells in Prostate Cancer: Possible Role for Interacting Interleukin 2‐T Cell Pharmacodynamics as a Determinant of Clinical Response
8个月前
已完结
Molecular correlates of clinical response and resistance to atezolizumab in combination with bevacizumab in advanced hepatocellular carcinoma
10个月前
已完结
皖公网安备34019202002308
